Correlation Between Cyclacel Pharmaceuticals and Zivo Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and Zivo Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and Zivo Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and Zivo Bioscience, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and Zivo Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of Zivo Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and Zivo Bioscience.

Diversification Opportunities for Cyclacel Pharmaceuticals and Zivo Bioscience

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Cyclacel and Zivo is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and Zivo Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zivo Bioscience and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with Zivo Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zivo Bioscience has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and Zivo Bioscience go up and down completely randomly.

Pair Corralation between Cyclacel Pharmaceuticals and Zivo Bioscience

If you would invest  181.00  in Zivo Bioscience on September 4, 2024 and sell it today you would earn a total of  0.00  from holding Zivo Bioscience or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy2.44%
ValuesDaily Returns

Cyclacel Pharmaceuticals  vs.  Zivo Bioscience

 Performance 
       Timeline  
Cyclacel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyclacel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Zivo Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zivo Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Zivo Bioscience is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Cyclacel Pharmaceuticals and Zivo Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyclacel Pharmaceuticals and Zivo Bioscience

The main advantage of trading using opposite Cyclacel Pharmaceuticals and Zivo Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, Zivo Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will offset losses from the drop in Zivo Bioscience's long position.
The idea behind Cyclacel Pharmaceuticals and Zivo Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data